| The role of common variants of ABCB1, CYP3A4, and CYP3A5 genes in lipid‐lowering efficacy and safety of simvastatin treatment M Fiegenbaum, FR da Silveira, CR Van der Sand, LC Van der Sand, ... Clinical Pharmacology & Therapeutics 78 (5), 551-558, 2005 | 252 | 2005 |
| Incontinentia pigmenti CS Poziomczyk, JK Recuero, L Bringhenti, FDS Maria, CW Campos, ... Anais brasileiros de dermatologia 89, 26-36, 2014 | 115 | 2014 |
| Pathology of TB/COVID-19 co-infection: the phantom menace GT Mousquer, A Peres, M Fiegenbaum Tuberculosis 126, 102020, 2021 | 98 | 2021 |
| Molecular basis of the Duffy blood group system G Höher, M Fiegenbaum, S Almeida Blood Transfusion 16 (1), 93, 2018 | 80 | 2018 |
| Determinants of variable response to simvastatin treatment: the role of common variants of SCAP, SREBF-1a and SREBF-2 genes M Fiegenbaum, FR Silveira, CR Van der Sand, LC Van der Sand, ... The pharmacogenomics journal 5 (6), 359-364, 2005 | 55 | 2005 |
| Pharmacogenetic study of apolipoprotein E, cholesteryl ester transfer protein and hepatic lipase genes and simvastatin therapy in Brazilian subjects M Fiegenbaum, FR da Silveira, CR Van der Sand, LC Van der Sand, ... Clinica chimica acta 362 (1-2), 182-188, 2005 | 50 | 2005 |
| Low-grade inflammation markers in children and adolescents: Influence of anthropometric characteristics and CRP and IL6 polymorphisms PF Todendi, LG Possuelo, EI Klinger, CP Reuter, MS Burgos, DJ Moura, ... Cytokine 88, 177-183, 2016 | 49 | 2016 |
| SLCO1B1 gene variability influences lipid-lowering efficacy on simvastatin therapy in Southern Brazilians VA Sortica, M Fiegenbaum, LO Lima, CR Van der Sand, LC Van der Sand, ... Clinical chemistry and laboratory medicine 50 (3), 441-448, 2012 | 46 | 2012 |
| Association between plasma lipid parameters and APOC3 genotypes in Brazilian subjects: effect of gender, smoking and APOE genotypes M Fiegenbaum, FM de Andrade, MH Hutz Clinica Chimica Acta 380 (1-2), 175-181, 2007 | 39 | 2007 |
| APOE polymorphism distribution among Native Americans and related populations DA Demarchi, FM Salzano, M Eugenia Altuna, M Fiegenbaum, K Hill, ... Annals of human biology 32 (3), 351-365, 2005 | 39 | 2005 |
| Metabolic changes associated with antiretroviral therapy in HIV-positive patients SEM Almeida, M Borges, M Fiegenbaum, CC Nunes, MLR Rossetti Revista de saude publica 43, 283-290, 2009 | 37 | 2009 |
| Further evidence for the association between obesity-related traits and the apolipoprotein A-IV gene M Fiegenbaum, MH Hutz International journal of obesity 27 (4), 484-490, 2003 | 37 | 2003 |
| Association of GPX1 and GPX4 polymorphisms with episodic memory and Alzheimer’s disease TJ da Rocha, MS Alves, CC Guisso, FM de Andrade, A Camozzato, ... Neuroscience Letters 666, 32-37, 2018 | 34 | 2018 |
| Leprosy in Southern Brazil: a twenty-year epidemiological profile AP Nazario, J Ferreira, L Schuler-Faccini, M Fiegenbaum, O Artigalás, ... Revista da Sociedade Brasileira de Medicina Tropical 50, 251-255, 2017 | 33 | 2017 |
| Impact of the Cytochrome P450 2B6 (CYP2B6) Gene Polymorphism c.516G>T (rs3745274) on Propofol Dose Variability AL Mourão, FG de Abreu, M Fiegenbaum European journal of drug metabolism and pharmacokinetics 41, 511-515, 2016 | 33 | 2016 |
| Prevalência de coinfecção tuberculose/HIV em pacientes do Centro de Saúde Modelo de Porto Alegre, Rio Grande do Sul JLC Rodrigues, M Fiegenbaum, AF Martins Sci Med 20 (3), 212-7, 2010 | 29 | 2010 |
| ESR1 and APOE gene polymorphisms, serum lipids, and hormonal replacement therapy S Almeida, M Fiegenbaum, FM de Andrade, MC Osório-Wender, MH Hutz Maturitas 54 (2), 119-126, 2006 | 28 | 2006 |
| The role of the genetic variants IRX3 rs3751723 and FTO rs9939609 in the obesity phenotypes of children and adolescents PF Todendi, AR de Moura Valim, E Klinger, CP Reuter, S Molina, ... Obesity Research & Clinical Practice 13 (2), 137-142, 2019 | 25 | 2019 |
| DNA methyltransferase haplotype is associated with Alzheimer's disease JC Pezzi, CMB Ens, EM Borba, AF Schumacher-Schuh, FM de Andrade, ... Neuroscience letters 579, 70-74, 2014 | 23 | 2014 |
| Genetic risk score based on fat mass and obesity-associated, transmembrane protein 18 and fibronectin type III domain containing 5 polymorphisms is associated with … PF Todendi, EI Klinger, ACR Geraldo, L Brixner, CP Reuter, ... British journal of nutrition 121 (1), 93-99, 2019 | 22 | 2019 |
